相似文献
1
The CALM and CALM/AF10 interactor CATS is a marker for proliferation.
Mol Oncol. 2008 Dec;2(4):356-67. doi: 10.1016/j.molonc.2008.08.001. Epub 2008 Sep 4.
2
The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
Oncogene. 2006 Jul 6;25(29):4099-109. doi: 10.1038/sj.onc.1209438. Epub 2006 Feb 20.
3
A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
Blood. 2013 Jun 6;121(23):4758-68. doi: 10.1182/blood-2012-06-435792. Epub 2013 Mar 13.
4
The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Oncogene. 2008 May 1;27(20):2886-96. doi: 10.1038/sj.onc.1210945. Epub 2007 Nov 26.
5
Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.
Cancer Sci. 2014 Mar;105(3):315-23. doi: 10.1111/cas.12347. Epub 2014 Feb 13.
6
Effects of iron depletion on CALM-AF10 leukemias.
Exp Hematol. 2014 Dec;42(12):1022-1030.e1. doi: 10.1016/j.exphem.2014.08.004. Epub 2014 Sep 3.
7
Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L.
Nat Cell Biol. 2006 Sep;8(9):1017-24. doi: 10.1038/ncb1464. Epub 2006 Aug 20.
8
A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Genes Chromosomes Cancer. 2003 Jan;36(1):26-36. doi: 10.1002/gcc.10136.
9
The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
Nat Commun. 2021 Jul 5;12(1):4130. doi: 10.1038/s41467-021-24418-9.
10
Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
Korean J Lab Med. 2010 Apr;30(2):117-21. doi: 10.3343/kjlm.2010.30.2.117.
引用本文的文献
1
The complex role and molecular mechanism of family with sequence similarity genes in cancer: a comprehensive review.
Discov Oncol. 2025 Jul 30;16(1):1443. doi: 10.1007/s12672-025-03241-4.
2
FAM64A silencing inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition in ovarian cancer cells via activating Hippo pathway.
Discov Oncol. 2025 Jun 20;16(1):1160. doi: 10.1007/s12672-025-02710-0.
3
FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation.
Endocr Relat Cancer. 2025 Jun 16;32(6). doi: 10.1530/ERC-24-0048. Print 2025 Jun 1.
4
FAM64A regulates the malignant phenotype and tumor microenvironment of non-small cell lung cancer by activating the JAK/STAT3/PDL1 axis.
J Mol Histol. 2025 Feb 24;56(2):95. doi: 10.1007/s10735-024-10339-6.
5
Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation.
PeerJ. 2023 Jul 17;11:e15703. doi: 10.7717/peerj.15703. eCollection 2023.
6
is a prognostic biomarker involved in immune microenvironment of clear cell renal cell carcinoma and associated with the transition from G1 phase to S phase.
Front Oncol. 2023 Jan 26;13:1035321. doi: 10.3389/fonc.2023.1035321. eCollection 2023.
7
Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients.
Front Immunol. 2022 Jul 15;13:946692. doi: 10.3389/fimmu.2022.946692. eCollection 2022.
8
FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1.
Int J Oral Sci. 2022 May 10;14(1):25. doi: 10.1038/s41368-022-00174-4.
9
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role.
Front Genet. 2021 Sep 14;12:687778. doi: 10.3389/fgene.2021.687778. eCollection 2021.
10
Tumor-promoting function of PIMREG in glioma by activating the β-catenin pathway.
3 Biotech. 2021 Aug;11(8):380. doi: 10.1007/s13205-021-02922-5. Epub 2021 Jul 23.
本文引用的文献
1
Evidence for CALM in directing VAMP2 trafficking.
Traffic. 2008 Mar;9(3):417-29. doi: 10.1111/j.1600-0854.2007.00694.x. Epub 2007 Dec 21.
2
The role of CALM-AF10 gene fusion in acute leukemia.
Leukemia. 2008 Apr;22(4):678-85. doi: 10.1038/sj.leu.2405074. Epub 2007 Dec 20.
3
The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Oncogene. 2008 May 1;27(20):2886-96. doi: 10.1038/sj.onc.1210945. Epub 2007 Nov 26.
4
AF10-dependent transcription is enhanced by its interaction with FLRG.
Biol Cell. 2007 Oct;99(10):563-71. doi: 10.1042/bc20060131.
5
Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice.
Cancer Res. 2007 Sep 1;67(17):8022-31. doi: 10.1158/0008-5472.CAN-06-3749.
6
Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.
Cancer Cell. 2006 Nov;10(5):363-74. doi: 10.1016/j.ccr.2006.08.023.
7
Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L.
Nat Cell Biol. 2006 Sep;8(9):1017-24. doi: 10.1038/ncb1464. Epub 2006 Aug 20.
8
The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
Oncogene. 2006 Jul 6;25(29):4099-109. doi: 10.1038/sj.onc.1209438. Epub 2006 Feb 20.
9
Nucleolar adaptation in human cancer.
Cancer Invest. 2005;23(7):599-608. doi: 10.1080/07357900500283085.
10
Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation.
Traffic. 2005 Dec;6(12):1225-34. doi: 10.1111/j.1600-0854.2005.00355.x.
Zotero 插件